HEALTH RESOURCE UTILIZATION OF SUBJECTS RECEIVING DENOSUMAB AND ZOLEDRONIC ACID IN A RANDOMIZED PHASE 3 TRIAL OF ADVANCED BREAST CANCER PATIENTS WITH BONE METASTASES

被引：1
|
作者：
Body, J. J. [1 ]
von Moos, R. [2 ]
Stopeck, A. [3 ]
Qian, Y. [4 ]
Braun, A. [4 ]
Chung, K. [4 ]
机构：
[1] Ctr Hosp Univ Brugmann, Brussels, Belgium
[2] Kantonsspital Graubunden, Chur, Switzerland
[3] Univ Arizona, Tucson, AZ USA
[4] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)72040-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A279 / A279
页数：1
相关论文
共 50 条
  • [1] Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 study
    Stopeck, A.
    Body, J. J.
    Fujiwara, Y.
    Lipton, A.
    Steger, G. G.
    Viniegra, M.
    Fan, M.
    Braun, A.
    Dansey, R.
    Jun, S.
    [J]. EJC SUPPLEMENTS, 2009, 7 (03): : 2 - 3
  • [2] Comparing the Effects of Denosumab and Zoledronic Acid on Pain Interference with Daily Functioning in a Randomized Phase 3 Trial of Patients with Breast Cancer and Bone Metastases
    Cleeland, C. S.
    Patrick, D. L.
    Fallowfield, L.
    Clemons, M.
    Lipton, A.
    Masuda, N.
    Qian, Y.
    Braun, A.
    Chung, K.
    [J]. CANCER RESEARCH, 2010, 70
  • [3] Randomized trial of denosumab versus zoledronic acid in prostate cancer patients with bone metastases and elevated bone turnover markers after receiving zoledronic acid therapy
    Bosserman, Linda
    Fizazi, Karim
    Lipton, Allan
    Rahim, Yasmin
    Suarez, Tirzo
    Fan, Michelle
    Wu, Ling
    Markus, Richard A.
    [J]. JOURNAL OF UROLOGY, 2007, 177 (04): : 335 - 336
  • [4] Breast cancer bone metastases: denosumab or zoledronic acid?
    Gabri van der Pluijm
    [J]. Nature Reviews Endocrinology, 2011, 7 : 134 - 135
  • [5] CANCER Breast cancer bone metastases: denosumab or zoledronic acid?
    van der Pluijm, Gabri
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (03) : 134 - 135
  • [6] Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
    Stopeck, Alison T.
    Lipton, Allan
    Body, Jean-Jacques
    Steger, Guenther G.
    Tonkin, Katia
    de Boer, Richard H.
    Lichinitser, Mikhail
    Fujiwara, Yasuhiro
    Yardley, Denise A.
    Viniegra, Maria
    Fan, Michelle
    Jiang, Qi
    Dansey, Roger
    Jun, Susie
    Braun, Ada
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (35) : 5132 - 5139
  • [7] Denosumab versus zoledronic acid in patients with bone metastases from castration-resistant prostate cancer: Results from a phase 3 randomized trial
    Brown, J.
    Carducci, M.
    Fizazi, K.
    Smith, M.
    Damiao, Damiao R.
    Karsh, L.
    Milecki, P.
    Wang, H.
    Dansey, R.
    Goessl, C.
    [J]. BONE, 2011, 48 (01) : S16 - S16
  • [8] A randomized phase III trial of denosumab versus zoledronic acid in patients with bone metastases from castration-resistant prostate cancer
    Fizazi, K.
    Carducci, M. A.
    Smith, M. R.
    Damiao, R.
    Brown, J. E.
    Karsh, L.
    Milecki, P.
    Wang, H.
    Dansey, R. D.
    Goessl, C. D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18)
  • [9] Pain Outcomes in a Randomized Phase 3 Clinical Trial of Denosumab Vs Zoledronic Acid (ZA) in Patients With Solid Tumours and Bone Metastases
    Fallowfield, L.
    von Moos, R.
    Patrick, D.
    Cleeland, C. S.
    Henry, D. H.
    Hirsh, V.
    Zarogoulidis, K.
    Ying, W.
    Cong, Z.
    Yeh, H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S485 - S485
  • [10] A double-blind randomized trial of Denosumab compared with Zoledronic acid for Treatment of Bone metastases in Patients with Advanced cancer (breast and prostate cancer excluded), or multiple myeloma.
    van Moos, R.
    Henry, D.
    Vadhan-Raj, S.
    Hungria, V.
    Spencer, A.
    Hirsh, V.
    Wang, J.
    Jun, S.
    Dansey, R.
    Yeh, H.
    [J]. ONKOLOGIE, 2010, 33 : 2 - 3
12345